United States · FDA National Drug Code directory
Loteprednol etabonate and Tobramycin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 46708-801_a6d68829-f7b6-4b9b-ad44-110c47609918
- Product NDC
- 46708-801
- Form
- SUSPENSION/ DROPS
- Composition / generic term
- Loteprednol etabonate and Tobramycin
- Labeler
- Alembic Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20251210
- Source listing expiry
- 20261231
Source-listed ingredients
- LOTEPREDNOL ETABONATE — 5 mg/mL
- TOBRAMYCIN — 3 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (46708-801-05) / 5 mL in 1 BOTTLE · 46708-801-05
- 1 BOTTLE in 1 CARTON (46708-801-10) / 10 mL in 1 BOTTLE · 46708-801-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →